Case Studies of Non-CNS Drugs to Minimise Brain Penetration - Nonsedative Antihistamines
| dc.contributor.author | Crowe, Andrew | |
| dc.date.accessioned | 2017-01-30T15:38:44Z | |
| dc.date.available | 2017-01-30T15:38:44Z | |
| dc.date.created | 2015-12-10T04:25:55Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Crowe, A. 2015. Case Studies of Non-CNS Drugs to Minimise Brain Penetration - Nonsedative Antihistamines. In Blood-Brain Barrier in Drug Discovery Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs, 463-481: John Wiley & Sons. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/48306 | |
| dc.description.abstract |
Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs Li Di, Edward H. Kerns ... 275–278, 280–281, 372, 389, 392 Free drug concentration see Unbound drug concentration Free drug hypothesis, 2, ... | |
| dc.publisher | John Wiley & Sons | |
| dc.title | Case Studies of Non-CNS Drugs to Minimise Brain Penetration - Nonsedative Antihistamines | |
| dc.type | Book Chapter | |
| dcterms.source.startPage | 463 | |
| dcterms.source.endPage | 481 | |
| dcterms.source.title | Blood-Brain Barrier in Drug Discovery Optimizing Brain Exposure of CNS Drugs and Minimizing Brain Side Effects for Peripheral Drugs | |
| dcterms.source.isbn | 1118788354 | |
| dcterms.source.chapter | 26 | |
| curtin.department | School of Pharmacy | |
| curtin.accessStatus | Fulltext not available |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||